vs

Side-by-side financial comparison of IDACORP INC (IDA) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.

Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $360.1M, roughly 1.7× IDACORP INC). Royalty Pharma plc runs the higher net margin — 34.4% vs 12.1%, a 22.3% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs -4.2%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs -7.2%).

IDACORP, Inc is an electricity holding company, incorporated in Idaho with headquarters in Boise. It comprises Idaho Power Company, IDACORP Financial and Ida-West Energy. It was formed on October 1, 1998.

Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.

IDA vs RPRX — Head-to-Head

Bigger by revenue
RPRX
RPRX
1.7× larger
RPRX
$622.0M
$360.1M
IDA
Growing faster (revenue YoY)
RPRX
RPRX
+9.0% gap
RPRX
4.8%
-4.2%
IDA
Higher net margin
RPRX
RPRX
22.3% more per $
RPRX
34.4%
12.1%
IDA
Faster 2-yr revenue CAGR
RPRX
RPRX
Annualised
RPRX
4.6%
-7.2%
IDA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IDA
IDA
RPRX
RPRX
Revenue
$360.1M
$622.0M
Net Profit
$43.6M
$214.2M
Gross Margin
Operating Margin
14.9%
62.4%
Net Margin
12.1%
34.4%
Revenue YoY
-4.2%
4.8%
Net Profit YoY
15.1%
2.9%
EPS (diluted)
$0.78
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IDA
IDA
RPRX
RPRX
Q4 25
$360.1M
$622.0M
Q3 25
$526.4M
$609.3M
Q2 25
$449.3M
$578.7M
Q1 25
$411.1M
$568.2M
Q4 24
$375.9M
$593.6M
Q3 24
$532.5M
$564.7M
Q2 24
$442.6M
$537.3M
Q1 24
$417.9M
$568.0M
Net Profit
IDA
IDA
RPRX
RPRX
Q4 25
$43.6M
$214.2M
Q3 25
$124.4M
$288.2M
Q2 25
$95.8M
$30.2M
Q1 25
$59.6M
$238.3M
Q4 24
$37.9M
$208.2M
Q3 24
$113.6M
$544.0M
Q2 24
$89.5M
$102.0M
Q1 24
$48.2M
$4.8M
Operating Margin
IDA
IDA
RPRX
RPRX
Q4 25
14.9%
62.4%
Q3 25
27.5%
70.1%
Q2 25
22.4%
36.3%
Q1 25
13.4%
94.0%
Q4 24
11.0%
60.9%
Q3 24
25.1%
Q2 24
23.3%
50.2%
Q1 24
11.9%
-13.0%
Net Margin
IDA
IDA
RPRX
RPRX
Q4 25
12.1%
34.4%
Q3 25
23.6%
47.3%
Q2 25
21.3%
5.2%
Q1 25
14.5%
41.9%
Q4 24
10.1%
35.1%
Q3 24
21.3%
96.3%
Q2 24
20.2%
19.0%
Q1 24
11.5%
0.8%
EPS (diluted)
IDA
IDA
RPRX
RPRX
Q4 25
$0.78
$0.49
Q3 25
$2.26
$0.67
Q2 25
$1.76
$0.07
Q1 25
$1.10
$0.55
Q4 24
$0.72
$0.46
Q3 24
$2.12
$1.21
Q2 24
$1.71
$0.23
Q1 24
$0.95
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IDA
IDA
RPRX
RPRX
Cash + ST InvestmentsLiquidity on hand
$215.7M
$618.7M
Total DebtLower is stronger
$3.3B
$9.0B
Stockholders' EquityBook value
$3.6B
$9.7B
Total Assets
$10.2B
$19.6B
Debt / EquityLower = less leverage
0.93×
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IDA
IDA
RPRX
RPRX
Q4 25
$215.7M
$618.7M
Q3 25
$333.2M
$938.9M
Q2 25
$474.5M
$631.9M
Q1 25
$634.5M
$1.1B
Q4 24
$368.9M
$929.0M
Q3 24
$427.9M
$950.1M
Q2 24
$169.6M
$1.8B
Q1 24
$157.6M
$843.0M
Total Debt
IDA
IDA
RPRX
RPRX
Q4 25
$3.3B
$9.0B
Q3 25
$8.9B
Q2 25
$8.0B
Q1 25
$7.6B
Q4 24
$3.1B
$7.6B
Q3 24
$7.6B
Q2 24
$7.6B
Q1 24
$6.1B
Stockholders' Equity
IDA
IDA
RPRX
RPRX
Q4 25
$3.6B
$9.7B
Q3 25
$3.5B
$9.6B
Q2 25
$3.4B
$9.5B
Q1 25
$3.3B
$9.8B
Q4 24
$3.3B
$10.3B
Q3 24
$3.3B
$10.3B
Q2 24
$3.2B
$9.8B
Q1 24
$2.9B
$9.9B
Total Assets
IDA
IDA
RPRX
RPRX
Q4 25
$10.2B
$19.6B
Q3 25
$10.1B
$19.3B
Q2 25
$9.9B
$18.3B
Q1 25
$9.6B
$17.6B
Q4 24
$9.2B
$18.2B
Q3 24
$9.1B
$18.0B
Q2 24
$8.7B
$17.7B
Q1 24
$8.3B
$16.1B
Debt / Equity
IDA
IDA
RPRX
RPRX
Q4 25
0.93×
0.92×
Q3 25
0.93×
Q2 25
0.84×
Q1 25
0.78×
Q4 24
0.92×
0.74×
Q3 24
0.74×
Q2 24
0.78×
Q1 24
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IDA
IDA
RPRX
RPRX
Operating Cash FlowLast quarter
$137.8M
$827.1M
Free Cash FlowOCF − Capex
$-216.2M
FCF MarginFCF / Revenue
-60.0%
Capex IntensityCapex / Revenue
98.3%
Cash ConversionOCF / Net Profit
3.16×
3.86×
TTM Free Cash FlowTrailing 4 quarters
$-577.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IDA
IDA
RPRX
RPRX
Q4 25
$137.8M
$827.1M
Q3 25
$162.8M
$702.6M
Q2 25
$176.9M
$364.0M
Q1 25
$124.3M
$596.1M
Q4 24
$136.4M
$742.5M
Q3 24
$201.9M
$703.6M
Q2 24
$146.4M
$658.2M
Q1 24
$109.7M
$664.6M
Free Cash Flow
IDA
IDA
RPRX
RPRX
Q4 25
$-216.2M
Q3 25
$-127.9M
Q2 25
$-156.4M
Q1 25
$-77.0M
Q4 24
$-48.9M
Q3 24
$-16.1M
Q2 24
$-199.6M
Q1 24
$-150.3M
FCF Margin
IDA
IDA
RPRX
RPRX
Q4 25
-60.0%
Q3 25
-24.3%
Q2 25
-34.8%
Q1 25
-18.7%
Q4 24
-13.0%
Q3 24
-3.0%
Q2 24
-45.1%
Q1 24
-36.0%
Capex Intensity
IDA
IDA
RPRX
RPRX
Q4 25
98.3%
Q3 25
55.2%
Q2 25
74.2%
Q1 25
49.0%
Q4 24
49.3%
Q3 24
41.0%
Q2 24
78.2%
Q1 24
62.2%
Cash Conversion
IDA
IDA
RPRX
RPRX
Q4 25
3.16×
3.86×
Q3 25
1.31×
2.44×
Q2 25
1.85×
12.06×
Q1 25
2.08×
2.50×
Q4 24
3.60×
3.57×
Q3 24
1.78×
1.29×
Q2 24
1.63×
6.45×
Q1 24
2.28×
139.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IDA
IDA

Retailrevenues$323.0M90%
Transmissionserviceswheeling$18.6M5%
Energyefficiencyprogramrevenues$11.7M3%
Wholesaleenergysales$10.5M3%
Otherrevenues$9.5M3%

RPRX
RPRX

Financial Royalty Assets$592.4M95%
Royalty Income Other$29.6M5%

Related Comparisons